Across TCGA pan-cancer cohorts, MEIG1 Mutation is linked to patient survival in 2 of 34 cancer types, making it a survival-associated MEIG1 data layer compared with 19 for mass-spec protein.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MEIG1 Mutation is associated with worse overall survival. In most high-consensus cancer types, elevated MEIG1 expression acts as an unfavorable survival marker.

BLCA and UCEC are the cancer types where MEIG1 Mutation most reproducibly stratifies survival.

Mutation survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	III,IV	0.120	0.684	<.001	24	view →
UCEC	OS	Median	IV	0.231	0.592	.036	6	view →

Pink = unfavorable, green = favorable. Showing the 2 strongest of 2 lineages.

Exploration

Same gene, other analysis: MEIG1 tumor-vs-normal RNA expression · all MEIG1 data types